Biotech · Private company · Chicago, IL, US

Nuago Therapeutics Inc

Track this companyFree. Adds Nuago Therapeutics Inc to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards2

Development of a DISE-inducing, short RNA therapeutic to treat ovarian cancerFiscal year 2025 · $400KNIH RePORTER 1R42CA291346-01A1 · fetched Nov 12, 2026
Development of a novel, RNA-interference-based therapeutic to treat prostate cancerFiscal year 2024 · $400KNIH RePORTER 1R41CA287846-01A1 · fetched Nov 12, 2026